Difference between revisions of "Team:Amsterdam/Human practices"
| Line 1: | Line 1: | ||
{{Amsterdam/navbar}} | {{Amsterdam/navbar}} | ||
<html> | <html> | ||
| − | <section id="Human Practices" class="wrapper | + | <section id="Human Practices" class="wrapper style3"> |
<header class="major"><h2>Human Practices</h2></header> | <header class="major"><h2>Human Practices</h2></header> | ||
| + | </section> | ||
| + | <section id="Overview" class ="wrapper style1"> | ||
| + | <div class = "container"> | ||
| + | <p> | ||
| + | Our human practices efforts centered around our collaboration with Synenergene, an organisation dedicated to fostering responsible research and innovation in synthetic biology. This year and last year, they selected a small group of iGEM teams to conduct real-time technology assessments of their projects, in which teams investigate potential applications and implications of their technology. Specifically, we developed short-term and long-term secnarios that describe how our consortium-based bioproduction technology could be developed and embedded in society. These scenarios will be used by Synenergene’s partners in workshop settings with various stakeholders, with the ultimate goal of ‘developing a socially robust SynBio innovation agenda.’ Besides the application scenarios, we also explored the potential wider problematic impacts of the development of our consortium technology in so-called techno-moral vignettes. Lastly, we presented our research at the stakeholder symposium on synthetic biology organised by the RIVM, where policy-makers and other government representatives engaged in debate with us and each other about the coming impact of synbio. | ||
| + | </p> | ||
| + | </div> | ||
</section> | </section> | ||
</html> | </html> | ||
Revision as of 14:23, 18 September 2015
Human Practices
Our human practices efforts centered around our collaboration with Synenergene, an organisation dedicated to fostering responsible research and innovation in synthetic biology. This year and last year, they selected a small group of iGEM teams to conduct real-time technology assessments of their projects, in which teams investigate potential applications and implications of their technology. Specifically, we developed short-term and long-term secnarios that describe how our consortium-based bioproduction technology could be developed and embedded in society. These scenarios will be used by Synenergene’s partners in workshop settings with various stakeholders, with the ultimate goal of ‘developing a socially robust SynBio innovation agenda.’ Besides the application scenarios, we also explored the potential wider problematic impacts of the development of our consortium technology in so-called techno-moral vignettes. Lastly, we presented our research at the stakeholder symposium on synthetic biology organised by the RIVM, where policy-makers and other government representatives engaged in debate with us and each other about the coming impact of synbio.